12 employees
BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests.
2021
$1.6M
from 2 investors over 2 rounds
BioMAdvanced Diagnostics raised $1.6M on September 27, 2022
Investors: Pays de la Loire Participations and SODERO GESTION